Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo.
Heat shock proteins (HSPs) function as molecular chaperones involved in protein folding, transport and degradation and, in addition, they can promote cell survival both in vitro and in vivo after a range of stresses. Although some in vivo studies have suggested that HSP27 and HSP70 can be neuroprotective, current evidence is limited, particularly when HSPs have been delivered after an insult. The effect of overexpressing HSPs after transient occlusion of the middle cerebral artery in rats was investigated by delivering an attenuated herpes simplex viral vector (HSV-1) engineered to express HSP27 or HSP70 30 mins after tissue reperfusion. Magnetic resonance imaging scans were used to determine lesion size and cerebral blood flow at six different time points up to 1 month after stroke. Animals underwent two sensorimotor tests at the same time points to assess the relationship between lesion size and function. Results indicate that post-ischaemic viral delivery of HSP27, but not of HSP70, caused a statistically significant reduction in lesion size and induced a significant behavioural improvement compared with controls. This is the first evidence of effective post-ischaemic gene therapy with a viral vector expressing HSP27 in an experimental model of stroke.
Badin
Romina A
RA
RCS Unit of Biophysics, UCL Institute of Child Health, London, UK. rabadin@yahoo.com
Modo
Michael
M
Cheetham
Mike
M
Thomas
David L
DL
Gadian
David G
DG
Latchman
David S
DS
Lythgoe
Mark F
MF
D000818:Animals; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics; D055551:HSP27 Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D018840:HSP70 Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D018259:Herpesvirus 1, Human / Q000235:genetics*; D007511:Ischemia / Q000235:genetics* / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
D055551:HSP27 Heat-Shock Proteins; D018840:HSP70 Heat-Shock Proteins
Stroke. 1997 Oct;28(10):2060-5; discussion 2066
9341719
Trends Neurosci. 1999 Dec;22(12):535-40
10542428
Neuron. 2002 Sep 26;36(1):45-56
12367505
Stroke. 1988 Sep;19(9):1083-92
3413804
Brain Res. 1994 Jan 21;634(2):235-44
8131073
Mol Cell Biol. 2000 Oct;20(19):7146-59
10982831
J Biol Chem. 1999 Jul 2;274(27):18947-56
10383393
J Cereb Blood Flow Metab. 2001 Nov;21(11):1303-9
11702045
J Biol Chem. 1996 Jul 12;271(28):16510-4
8663291
Annu Rev Biochem. 1998;67:425-79
9759494
Stroke. 1995 Dec;26(12):2313-9; discussion 2319-20
7491657
J Cereb Blood Flow Metab. 2006 Mar;26(3):371-81
16079790
J Cereb Blood Flow Metab. 2006 Jan;26(1):38-47
15988477
Cell Death Differ. 2002 May;9(5):483-5
11973606
Arch Intern Med. 2000 Nov 27;160(21):3196-206
11088079
J Cereb Blood Flow Metab. 1996 Nov;16(6):1236-49
8898697
Pharmacol Ther. 1998 Nov;80(2):183-201
9839771
J Cell Sci. 1997 Feb;110 ( Pt 3):357-68
9057088
J Neurochem. 1999 Jul;73(1):229-36
10386975
J Neurosci Methods. 2000 Dec 15;104(1):99-109
11163416
Am J Physiol Renal Physiol. 2005 Jun;288(6):F1236-42
15701813
Stroke. 1994 Oct;25(10):1973-6
8091440
Pharmacol Biochem Behav. 1982 Mar;16(3):455-62
7079281
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12766-71
11606760
J Neurosci. 2003 Jan 15;23(2):510-7
12533611
Exp Neurol. 1988 Dec;102(3):318-24
3197789
Curr Neurovasc Res. 2004 Jan;1(1):21-7
16181063
Trends Pharmacol Sci. 1998 Feb;19(2):59-66
9550943
Magn Reson Imaging. 1995;13(1):73-80
7898282
Trends Neurosci. 1999 Mar;22(3):97-9
10199631
Nat Cell Biol. 2000 Aug;2(8):476-83
10934467
Magn Reson Med. 1995 Aug;34(2):139-43
7476070
Brain Res. 1992 Mar 20;575(2):238-46
1571783
Cell Stress Chaperones. 1998 Dec;3(4):228-36
9880235
Mol Cell Biol. 2002 Feb;22(3):816-34
11784858
J Biol Chem. 1999 Nov 19;274(47):33235-43
10559197
J Biol Chem. 2003 May 30;278(22):19956-65
12639970
J Cereb Blood Flow Metab. 1996 Jul;16(4):705-13
8964811
Glia. 2002 Apr 1;38(1):1-14
11921199
Phys Med Biol. 2000 Aug;45(8):R97-138
10958179